254-S
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryThe pharmacokinetics of (glycolato-0,0′)-diammine platinum (II) (254-S; NSC 375101D), one of the new platinum analogues…
Background. Based on the fact that combination chemotherapy with cisplatin, ifosfamide, and bleomycin generated a 69% response…
A phase II clinical study of 254-S, a new anticancer platinum complex for gastrointestinal cancers, was conducted by the 254-S…
A phase II study of 254-S was conducted in 134 patients with gynecological malignancies by the gynecology section of the 254-S…
A phase II clinical study of 254-S, a new anticancer platinum complex, for cervical cancer was conducted by the 254-S Cervical…
A late phase II clinical study of 254-S, a new anticancer platinum complex, for head and neck cancer was conducted by the 254-S…
A phase II clinical study of 254-S, a new anticancer platinum complex, for primary lung cancer was conducted by the 254-S Lung…
An early phase II clinical study of 254-S, a new anticancer platinum complex, for head and neck cancer was conducted by the 254-S…
A phase I study of cis-diammine(glycolato)platinum (254-S; NSC 375101D) was conducted in 15 patients with refractory or relapsing…